248 related articles for article (PubMed ID: 26744512)
1. Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina.
Çimen T; Efe TH; Akyel A; Sunman H; Algül E; Şahan HF; Erden G; Özdemir Ş; Alay EF; Doğan M; Yeter E
Angiology; 2016 Oct; 67(9):846-53. PubMed ID: 26744512
[TBL] [Abstract][Full Text] [Related]
2. Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association With Coronary Artery Disease in Patients With Hypertension.
Xiong C; Zhao ZW; Chen ZY; Wu LZ; Luo YK; Hu FD; Lin CG; Chen LL
J Investig Med; 2015 Oct; 63(7):867-70. PubMed ID: 26200037
[TBL] [Abstract][Full Text] [Related]
3. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.
Kose M; Emet S; Akpinar TS; Kocaaga M; Cakmak R; Akarsu M; Yuruyen G; Arman Y; Tukek T
Angiology; 2015 Sep; 66(8):727-31. PubMed ID: 25168956
[TBL] [Abstract][Full Text] [Related]
4. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension.
Wang XS; Yang W; Luo T; Wang JM; Jing YY
Genet Test Mol Biomarkers; 2015 Mar; 19(3):124-7. PubMed ID: 25588082
[TBL] [Abstract][Full Text] [Related]
5. Endocan Levels and Coronary Collateral Circulation in Stable Angina Pectoris: A Pilot Study.
Gok M; Kundi H; Kiziltunc E; Topcuoglu C; Ornek E
Angiology; 2018 Jan; 69(1):43-48. PubMed ID: 28393589
[TBL] [Abstract][Full Text] [Related]
6. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
[TBL] [Abstract][Full Text] [Related]
7. Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea.
Sun H; Fang F; Li K; Zhang H; Zhang M; Zhang L; Li J; Qin Y; Wei Y
Respir Res; 2019 Aug; 20(1):188. PubMed ID: 31429753
[TBL] [Abstract][Full Text] [Related]
8. Plasma Endocan Levels in Patients With Isolated Coronary Artery Ectasia.
Turan T; Akyuz AR; Aykan AC; Kul S; Cirakoglu OF; Aslan AO; Gul I; Uçar U; Demir S; Celik S
Angiology; 2016 Nov; 67(10):932-936. PubMed ID: 26980772
[TBL] [Abstract][Full Text] [Related]
9. Serum endocan levels in patients with cardiac syndrome X.
Efe SC; Demirci K; Ozturk S; Gurbuz AS; Poci N; Kilicgedik A; Guler A; Yilmaz MF; İzgi IA; Kirma C
Herz; 2018 Jun; 43(4):359-363. PubMed ID: 28589439
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the serum alkaline phosphatase level and the severity of coronary artery disease.
Sahin I; Karabulut A; Gungor B; Avci II; Okuyan E; Kizkapan F; Yildiz SS; Can MM; Dinckal M
Coron Artery Dis; 2014 Jun; 25(4):349-52. PubMed ID: 24769515
[TBL] [Abstract][Full Text] [Related]
11. [Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon].
Sığırcı S; Sarıkaya R; Keskin K; Yıldız SS; Pilten Güzel S; Çetinkal G; Önur İ; Kılıçkesmez KO
Turk Kardiyol Dern Ars; 2019 Jun; 47(4):251-257. PubMed ID: 31219439
[TBL] [Abstract][Full Text] [Related]
12. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B
Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287
[TBL] [Abstract][Full Text] [Related]
13. Coronary Microvascular Dysfunction, Microvascular Angina, and Management.
Löffler AI; Bourque JM
Curr Cardiol Rep; 2016 Jan; 18(1):1. PubMed ID: 26694723
[TBL] [Abstract][Full Text] [Related]
14. Endocan is useful biomarker of survival and severity in sepsis.
Mihajlovic DM; Lendak DF; Brkic SV; Draskovic BG; Mitic GP; Novakov Mikic AS; Cebovic TN
Microvasc Res; 2014 May; 93():92-7. PubMed ID: 24769132
[TBL] [Abstract][Full Text] [Related]
15. Endocan as a marker of disease severity in pulmonary thromboembolism.
Kuluöztürk M; İn E; İlhan N
Clin Respir J; 2019 Dec; 13(12):773-780. PubMed ID: 31556240
[TBL] [Abstract][Full Text] [Related]
16. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study.
Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Kurtoglu E; Demir M; Celik T; Turker T; Iyisoy A
Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320
[TBL] [Abstract][Full Text] [Related]
17. Elevated endocan concentration is associated with coronary slow flow.
Ye MF; Zhao ZW; Luo YK; Dong XF; Yan YM
Scand J Clin Lab Invest; 2016 Sep; 76(5):345-8. PubMed ID: 27180882
[TBL] [Abstract][Full Text] [Related]
18. Serum Endothelial Cell-Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance.
Qiu CR; Fu Q; Sui J; Zhang Q; Wei P; Wu Y; Zhu K; Lu Y; Zong B
Angiology; 2017 Apr; 68(4):354-359. PubMed ID: 27225701
[TBL] [Abstract][Full Text] [Related]
19. Do ANGPTL-4 and galectin-3 reflect the severity of coronary artery disease?
Goenka L; George M; Singh V; Jena A; Seshadri D; Karunakaran V; Elumalai DV; Rani J; Kaliappan I
Ther Adv Cardiovasc Dis; 2017 Oct; 11(10):261-270. PubMed ID: 28795637
[TBL] [Abstract][Full Text] [Related]
20. Postoperative serum levels of Endocan are associated with the duration of norepinephrine support after coronary artery bypass surgery.
Bouglé A; Allain PA; Favard S; Ait Hamou N; Carillion A; Leprince P; Granger B; Amour J
Anaesth Crit Care Pain Med; 2018 Dec; 37(6):565-570. PubMed ID: 29476941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
